This is a general term for tumors or growths in the ovary. These growths can be non-cancerous (benign) or cancerous (malignant). They are often referred to as ovarian cancer when they are cancerous.
Every report comes from a Lived member, sent anonymously.
Have you tried Carboplatin for Ovarian Tumors?
An ovarian tumor is an abnormal growth that forms in or on an ovary, one of the two almond-sized glands beside the uterus that release eggs and make the hormones estrogen and progesterone. The term covers a wide range. Many ovarian tumors are benign (not cancer), some are borderline, and some are cancers that can spread beyond the ovary. They differ from the common fluid-filled cysts that form during ovulation and usually go away on their own, although the two can look alike on a scan. Tumors are grouped by the kind of cell they start in. Epithelial tumors begin in the cells that cover the ovary or line the nearby fallopian tube, and they are the most common kind. They include benign cystadenomas, borderline tumors (also called tumors of low malignant potential, which grow slowly and are far less dangerous than most cancers) and epithelial carcinomas, which make up about 85 to 90 percent of ovarian cancers. Germ cell tumors start in the egg-producing cells and mostly affect teenagers and young women. The most common is a benign mature teratoma, or dermoid cyst, which can contain hair, skin or even teeth. Stromal tumors start in the tissue that holds the ovary together and makes its hormones, and they are less common. Ovarian cancer matters because it often causes no clear symptoms early, so it is frequently found only after it has spread within the abdomen. Cancers of the fallopian tube and of the peritoneum (the lining of the abdomen) behave and are treated the same way, and many cancers once thought to start in the ovary are now believed to begin in the fallopian tube.
Ovarian cancer develops when changes in a cell's DNA let it grow out of control. Most of these changes build up during a person's lifetime for reasons that usually can't be identified, but some are inherited. The best known inherited changes are in the BRCA1 and BRCA2 genes, which normally help cells repair damaged DNA. About 39 to 58 percent of women who inherit a harmful BRCA1 change, and 13 to 29 percent with a harmful BRCA2 change, develop ovarian cancer during their lifetime, compared with about 1 percent of women overall. Lynch syndrome, an inherited condition best known for raising colon cancer risk, also raises ovarian cancer risk. Age is the other major factor: about half of people diagnosed are 63 or older. Other things linked to higher risk include a mother, sister, grandmother or aunt with ovarian cancer, endometriosis, menopausal hormone therapy, excess weight, being tall and never having been pregnant. These are associations rather than causes, and most people with one or more of them never develop ovarian cancer. Some factors are linked to lower risk, including past use of birth control pills (a protective effect that can last decades after stopping), pregnancy, breastfeeding, and surgery that ties or removes the fallopian tubes. Benign tumors and germ cell tumors follow a different pattern. Teratomas may be present from birth and grow during the reproductive years, and germ cell tumors mostly appear in teens and young adults rather than after menopause.
Ovarian tumors are found in two main ways: during a pelvic exam or scan done for another reason, or when symptoms lead to testing. The central test is a pelvic ultrasound, often done with a slim probe placed in the vagina (transvaginal ultrasound). It shows the size of the growth and whether it is simple fluid or has solid parts, which helps separate an ordinary cyst from something that needs closer attention. A blood test for CA-125 (cancer antigen 125), a protein many ovarian cancers release, is often added. A raised level, together with concerning ultrasound or exam findings, increases suspicion of cancer, especially after menopause. It is not a diagnosis by itself, because endometriosis and other noncancerous conditions can also raise it. When a germ cell tumor is suspected in a younger person, other blood markers are checked. CT (computed tomography) scans of the abdomen, pelvis and chest help show whether a cancer may have spread. The only way to know for certain whether a tumor is cancer, borderline or benign is to examine the tissue under a microscope, usually after the growth is removed in surgery. When cancer is suspected, surgeons try to take the growth out in one piece, and guidelines recommend evaluation by a gynecologic oncologist, a surgeon who specializes in cancers of the female reproductive organs. Everyone diagnosed with epithelial ovarian cancer should be offered genetic testing, both of inherited genes such as BRCA1 and BRCA2 and of the tumor itself, because the results shape treatment and can matter for relatives. There is no effective screening test for people without symptoms. The US Preventive Services Task Force found that routine ultrasound or CA-125 testing does not reduce deaths from ovarian cancer and leads to many false alarms and unnecessary surgery. People who carry a known high-risk inherited change are managed differently, usually with specialist advice.
Treatment depends first on whether a growth is benign, borderline or cancer, and then on its type, its stage, the person's age and whether they want to have children in the future. Many simple-looking cysts are watched with repeat ultrasounds, since common cysts often disappear within one or two menstrual cycles. Surgery is recommended when a growth is large, causing symptoms, not going away or suspicious for cancer. For a tumor thought to be benign, surgeons usually use laparoscopy (surgery through small cuts using a thin camera) and may remove only the growth (cystectomy), keeping the ovary, or remove the whole ovary (oophorectomy). Open surgery through a larger incision is used when cancer is suspected or the growth is too large to remove intact through small cuts. For epithelial ovarian cancer, treatment usually combines surgery and chemotherapy. Surgery typically removes the uterus, both ovaries and fallopian tubes, and the omentum (a fatty apron of tissue in the abdomen), checks lymph nodes and aims to remove all visible cancer, because how much can be removed strongly affects the outlook. Chemotherapy with a platinum drug and a taxane, most often carboplatin and paclitaxel, usually follows. When cancer is widespread or surgery is too risky at first, chemotherapy may be given first to shrink it, with surgery after a few cycles. For some early cancers, borderline tumors and germ cell tumors in people who want to preserve fertility, surgeons may remove only the affected ovary and tube. After first-line chemotherapy, maintenance treatment can help delay the cancer's return. PARP inhibitors are daily pills that block PARP, a DNA-repair enzyme cancer cells depend on, and they are used mainly for cancers with a BRCA change or a related repair defect, which is one reason genetic testing matters. Olaparib (Lynparza) and niraparib (Zejula) are the main examples. They commonly cause nausea, tiredness and low blood counts, so blood tests are checked regularly. Bevacizumab (Avastin, also available as biosimilars), an intravenous drug that blocks the blood supply tumors need to grow, may be added to chemotherapy. Germ cell cancers usually respond well to surgery followed, when needed, by chemotherapy. Clinical trials are an option at many stages.
The outlook depends far more on the type of tumor than on the label ovarian tumor. Benign tumors are usually cured by removing them, and many people keep the ovary or at least one ovary and their fertility. Borderline tumors grow slowly and are much less likely to threaten life than most ovarian cancers, though regular ultrasounds continue after surgery because they can come back. Germ cell and stromal cancers generally do well: in US data, about 93 percent of people with ovarian germ cell cancers and 91 percent with stromal cancers were alive five years after diagnosis. For the more common epithelial ovarian cancer, stage at diagnosis matters most. About 92 percent of people whose cancer is still confined to the ovary are alive five years later, compared with about 32 percent when it has reached distant organs. Because many cases are found after spread, advanced cancer often returns months or years after first treatment, and many people go through more than one course of treatment over time, sometimes with long stretches of good health between them. These figures describe past groups of patients and can't predict one person's course, and the death rate from ovarian cancer has fallen by 45 percent since the 1970s as treatment has improved. First treatment usually spans several months. Recovery from major abdominal surgery takes time, and chemotherapy commonly brings nausea, hair loss, tiredness and a higher risk of infection while blood counts are low. Some drugs cause numbness or tingling in the hands and feet that can linger. Removing both ovaries before menopause brings on menopause right away, with symptoms such as hot flashes that are worth discussing with the care team. In advanced disease, fluid can build up in the belly (ascites) and the cancer can press on or block the bowel; both can be relieved with procedures. After treatment, follow-up visits with exams and tests such as CA-125 look for any return. If genetic testing finds an inherited change, close relatives can be offered testing too.
See a doctor if bloating, pelvic or belly pain, trouble eating or feeling full quickly, or needing to urinate urgently or often are new for you and happen on most days (more than about 12 times a month) or keep getting worse. Also arrange a visit for any vaginal bleeding after menopause, a belly that is swelling without weight gain elsewhere, or a family history of ovarian, breast or related cancers, which may call for genetic counseling. During chemotherapy, call your care team right away for a fever of 100.5°F (38°C) or higher or chills, since infections can become serious quickly when blood counts are low. Tell the team promptly about belly pain with repeated vomiting or growing belly swelling, which can mean a bowel blockage or fluid buildup. Sudden, severe pain in the lower belly or pelvis, often on one side and sometimes with nausea and vomiting, can mean an ovary has twisted on itself (torsion) or a cyst or tumor has burst or bled. Get emergency care right away, because prompt surgery can save the ovary.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Ovarian Tumors is like, what's helped you, or ask the community a question.